Chief Scientific Officer @ TrisaQ Inc. (February 2020 - October 2020)
Chief Technology Officer and Head of Research @ Agenus Inc (January 2017 - January 2020)
VP PreClinical Development @ Agenus Inc (January 2015 - January 2017)
Managing Director @ Actigen (November 2012 - December 2014)
SVP Research and Development @ Affitech A/S (September 2009 - November 2012)
CEO and President @ (May 2008 - November 2009)
SVP Biopharmaceuticals @ (January 2006 - January 2007)
SVP Drug Discovery @ Cambridge Antibody Technology (January 1994 - January 2007)
Alex Duncan Education
University of Cambridge
PhD (Molecular Immunology)
1984-1987
Alex Duncan Skills
Biotechnology
Biopharmaceuticals
Drug Development
Molecular Biology
Drug Discovery
R&D
Pharmaceutical Industry
Lifesciences
Immunology
Technology Transfer
Clinical Development
Biochemistry
Oncology
Genomics
Medical Devices
Commercialization
Protein Chemistry
High Throughput Screening
Cell
Life Sciences
Vaccines
Leadership
Microsoft Excel
Business Strategy
Alex Duncan Summary
Alex Duncan, based in Boston, MA, US, is currently a Chief Scientific Officer at Walden Biosciences Inc.. Alex Duncan brings experience from previous roles at TrisaQ Inc., Agenus Inc and Actigen. Alex Duncan holds a 1984 - 1987 PhD in Molecular Immunology @ University of Cambridge. With a robust skill set that includes Biotechnology, Biopharmaceuticals, Drug Development, Molecular Biology, Drug Discovery and more. Alex Duncan has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Alex Duncan?
Find contact details for 700 million professionals.